HALO
Halozyme Therapeutics, Inc.#78 · 2022BreakoutBYearly return
+39%
Peak return
+45%
Max drawdown
-28%
ADR (20 days)
+2.7%
Base
22 days / -18.5%
Prior run
+32%
Breakout volume
2.5x
Pivot
$50.35
Catalyst Earnings/Guidance2022-11-09Halozyme's (HALO) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research
Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare HALO with the current market directly.